BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fändrich F. Cell therapy approaches aiming at minimization of immunosuppression in solid organ transplantation. Current Opinion in Organ Transplantation 2010;15:703-8. [DOI: 10.1097/mot.0b013e328340669a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang Q, Liu Y, Wu Y, Wen J, Man C. Immune function of miR-214 and its application prospects as molecular marker. PeerJ 2021;9:e10924. [PMID: 33628646 DOI: 10.7717/peerj.10924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chin LY, Carroll C, Raigani S, Detelich DM, Tessier SN, Wojtkiewicz GR, Schmidt SP, Weissleder R, Yeh H, Uygun K, Parekkadan B. Ex vivo perfusion-based engraftment of genetically engineered cell sensors into transplantable organs. PLoS One 2019;14:e0225222. [PMID: 31790444 DOI: 10.1371/journal.pone.0225222] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
3 Pőcze B, Németh P, Langer R. [Recent options in drug therapy after solid organ transplantation]. Orv Hetil 2012;153:1294-301. [PMID: 22890176 DOI: 10.1556/OH.2012.29343] [Reference Citation Analysis]